|
Age (year)
|
72.3 ± 5.7
|
77.6 ± 6.3
|
< 0.001*
|
|
Gender, n (%)
| | |
0.449
|
|
Male
|
238
|
37
|
–
|
|
Female
|
75
|
15
|
–
|
|
BMI (kg/m2)
|
21.2 ± 2.1
|
20.9 ± 1.9
|
0.331
|
|
Comorbidities, n (%)
| | |
–
|
|
Hypertension
|
38
|
13
|
0.013*
|
|
Diabetes
|
27
|
10
|
0.019*
|
|
Hyperlipidaemia
|
22
|
7
|
0.122
|
|
Heavy drinkers, n (%)
|
26
|
7
|
0.230
|
|
Current smokers, n (%)
|
33
|
10
|
0.072
|
|
ASA grade, n (%)
| | |
0.015*
|
|
I/II
|
247
|
33
|
–
|
|
III/IV
|
66
|
19
|
–
|
|
Abdominal surgery history, n (%)
|
26
|
7
| |
|
Tumor location, n (%)
| | |
0.449
|
|
Cardia
|
32
|
6
|
–
|
|
Pylorus
|
201
|
28
|
–
|
|
Corpus
|
67
|
14
|
–
|
|
Total
|
13
|
4
|
–
|
|
Histologic type
| | |
0.177
|
|
Differentiated
|
221
|
30
|
–
|
|
Undifferentiated
|
33
|
8
|
–
|
|
Signet-ring cell carcinoma
|
59
|
14
|
–
|
|
Pathological type
| | |
0.210
|
|
Ulcerative
|
273
|
42
|
–
|
|
Non-ulcerative
|
40
|
10
|
–
|
|
Tumor size (cm)
|
4.3 ± 1.9
|
4.5 ± 2.1
|
0.489
|
|
Extent of resection
| | |
0.741
|
|
Distal gastrectomy
|
185
|
32
|
–
|
|
Total gastrectomy
|
128
|
20
|
–
|
|
T stage
| | |
0.876
|
|
Tis/T1/T2
|
130
|
21
|
–
|
|
T3/T4
|
183
|
31
|
–
|
|
N stage
| | |
0.952
|
|
N0
|
101
|
17
|
–
|
|
N1/N2/N3
|
212
|
35
|
–
|
|
TNM stage
| | |
0.654
|
|
I
|
77
|
11
|
–
|
|
II
|
89
|
13
|
–
|
|
III
|
147
|
28
|
–
|
|
Operation time (min)
|
234.6 ± 31.3
|
245.7 ± 38.2
|
0.023*
|
|
Estimated blood loss (mL)
|
187.9 ± 78.8
|
217.2 ± 70.6
|
0.012*
|
|
Intraoperative fluid utilization (mL)
|
1910.3 ± 245.3
|
2014.3 ± 306.4
|
0.007*
|
|
Perioperative blood transfusion, n (%)
|
105
|
16
|
0.694
|
|
Time to first flatus (d)
|
2.9 ± 0.7
|
3.0 ± 0.9
|
0.362
|
|
Time to ambulation (d)
|
2.1 ± 0.7
|
2.2 ± 0.6
|
0.332
|
|
Time to first liquid intake (d)
|
3.9 ± 1.1
|
4.0 ± 1.3
|
0.555
|
|
Time to first soft intake (d)
|
5.4 ± 1.3
|
5.3 ± 1.5
|
0.616
|
